Sarepta Therapeutics (SRPT) PT Raised to $185 at Janney

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Sarepta Therapeutics (SRPT) PT Raised to $185 at Janney

3 Reasons the Sarepta Therapeutics (SRPT) Deal Looks Favorable - Citi

December 26, 2019 6:28 AM EST

Citi analyst, Joel Beatty, reiterated a Buy rating and $177.00 price target on Sarepta Therapeutics (NASDAQ: SRPT) after the company announced a deal that would provide an upfront $1.15B upfront payment, ongoing royalty payments and development cost sharing in exchange for non-U.S. product rights.

The analyst believes this benefits... More